TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

7.90$ -6.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
– +33.6% -6.1% +12.7% -56.9% -59.1% -8.8% +1,281.9% -17.7%
– -39.9% -81.0% +189.8% -51.5% +83.8% -9.7% +1,311.1% -19.7%
– -39.0% -86.3% +131.7% -71.3% +496.8% -21.7% +1,537.2% -46.7%
– -39.0% -86.3% +131.7% -71.3% +496.8% -21.7% +1,537.2% -20.7%
– -36.8% +105.2% +0.8% +392.9% – – – –
– -25.4% -2.9% +157.1% +7.2% – – – –
– -9.7% +0.0% +0.0% – – – – –
– +4.2% +46.6% -3.5% -34.1% – – – –
– +93.4% +1.9% +16.7% -57.8% +195.8% +41.4% -82.4% -34.9%
– +28.6% +29.6% +52.6% -75.1% -48.1% +892.5% -52.3% -27.5%
– -54.3% +245.8% +126.3% -78.9% -95.6% +20,756.9% -86.2% -47.9%
– +3,234.1% +1,510.0% -62.0% +2.2% -63.3% -17.5% +7.0% +34.0%
– – – – – – +264.2% -69.5% –
– -11.5% -19.4% +4.6% -54.9% -615.1% – – -15.8%
– – – – – – – – –
– +0.0% +0.0% +21.3% +22.7% -18.5% +0.1% +4.8% +0.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?